Education
About Us
Working with TipRanks
Follow Us
Thomas Stankovich Insider Profile
18 Followers
Thomas Stankovich, Former Vice President & CFO at Response Genetics, holds 22.78K shares in ReShape Lifesciences (Ticker: RSLS), holds 4.63K shares in ReShape Lifesciences (Ticker: ~RSLS), holds 67.49K shares in Response Genetics (Ticker: RGDXQ). Most recently, Thomas Stankovich Sold ― shares of ReShape Lifesciences on Aug 13, 2024 for an estimated value of 38.78.
Thomas Stankovich Response Genetics (RGDXQ)Former Vice President & CFO
Response Genetics (RGDXQ)
Former Vice President & CFO
Ranked #296 out of 100,956 Corporate Insiders
Profitable Transactions
20 out of 26 Profitable Transactions
Average Return
+43.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas Stankovich holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 06, 2022 - Jul 06, 2023
Return:+95.00%
The most profitable trade made by Thomas Stankovich
Thomas Stankovich's Trading History
Response Genetics
Dec 14, 2009
Former Vice President & CFO
Informative Buy
9.43K
$944.83
ReShape Lifesciences
Sep 17, 2020
―
Informative Buy
1.59K
$29.66K
ReShape Lifesciences
Aug 13, 2024
CFO
Informative Sell
38.78
$20.61K
List of latest transactions for each holding click on a transaction to see Thomas Stankovich's performance on stock
You May Also Like
Thomas Stankovich insider profile FAQ
What is the percentage of profitable transactions made by Thomas Stankovich?
The percentage of profitable transactions made by Thomas Stankovich is 77%.
What is the average return per transaction made by Thomas Stankovich?
The average return per transaction made by Thomas Stankovich is 43.70%.
What stocks does Thomas Stankovich hold?
Thomas Stankovich holds: RGDXQ, ~RSLS, RSLS stocks.
What was Thomas Stankovich’s latest transaction?
Thomas Stankovich latest transaction was an Informative Sell of $38.78.
What was Thomas Stankovich's most profitable transaction?
Thomas Stankovich’s most profitable transaction was an Informative Sell of RSLS stock on July 6, 2022. The return on the trade was 95.00%.
What is Thomas Stankovich's role in Response Genetics?
Thomas Stankovich's role in Response Genetics is Former Vice President & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.